ATE92317T1 - Verwendung von pyrrol(3,2,1-hi>indol-derivaten zur herstellung eines arzneimittels zur behandlung von diabetes. - Google Patents

Verwendung von pyrrol(3,2,1-hi>indol-derivaten zur herstellung eines arzneimittels zur behandlung von diabetes.

Info

Publication number
ATE92317T1
ATE92317T1 AT88402156T AT88402156T ATE92317T1 AT E92317 T1 ATE92317 T1 AT E92317T1 AT 88402156 T AT88402156 T AT 88402156T AT 88402156 T AT88402156 T AT 88402156T AT E92317 T1 ATE92317 T1 AT E92317T1
Authority
AT
Austria
Prior art keywords
diabetes
treatment
medication
pyrrol
manufacture
Prior art date
Application number
AT88402156T
Other languages
English (en)
Inventor
Dennis Bigg
Salomon Langer
Claude Morel
Mireille Sevrin
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Application granted granted Critical
Publication of ATE92317T1 publication Critical patent/ATE92317T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
AT88402156T 1987-10-07 1988-08-25 Verwendung von pyrrol(3,2,1-hi>indol-derivaten zur herstellung eines arzneimittels zur behandlung von diabetes. ATE92317T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8713831A FR2621486B1 (fr) 1987-10-07 1987-10-07 Utilisation de derives de pyrrolo(3,2,1-hi)indole pour obtenir un medicament destine au traitement du diabete
EP88402156A EP0311467B1 (de) 1987-10-07 1988-08-25 Verwendung von Pyrrol[3,2,1-hi]indol-Derivaten zur Herstellung eines Arzneimittels zur Behandlung von Diabetes

Publications (1)

Publication Number Publication Date
ATE92317T1 true ATE92317T1 (de) 1993-08-15

Family

ID=9355590

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88402156T ATE92317T1 (de) 1987-10-07 1988-08-25 Verwendung von pyrrol(3,2,1-hi>indol-derivaten zur herstellung eines arzneimittels zur behandlung von diabetes.

Country Status (6)

Country Link
US (1) US4904684A (de)
EP (1) EP0311467B1 (de)
JP (1) JPH0651621B2 (de)
AT (1) ATE92317T1 (de)
DE (1) DE3882875T2 (de)
FR (1) FR2621486B1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2664086T3 (es) 2005-12-30 2018-04-18 Zensun (Shanghai) Science & Technology, Co., Ltd. Liberación extendida de neurregulina para mejorar la función cardíaca

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE755270A (fr) * 1969-08-27 1971-02-25 Sandoz Sa Nouveaux derives du benzo(cd)indole, leur preparation et medicaments contenant ces derives
DE3049405A1 (de) * 1980-12-23 1982-07-15 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue derivate von antiphlogistisch wirksamen carbonsaeuren, ihre herstellung und medizinische anwendung
NZ201219A (en) * 1981-07-28 1984-10-19 Reckitt & Colmann Prod Ltd Dihydrobenzofuranyl-2-imidazolines and pharmaceutical compositions
KR910005851B1 (ko) * 1983-12-12 1991-08-05 신 떼라보 피롤로[3,2,1-hi]인돌유도체 및 약학적으로 허용되는 그의 산부가염을 제조하는 방법

Also Published As

Publication number Publication date
FR2621486A1 (fr) 1989-04-14
DE3882875D1 (de) 1993-09-09
DE3882875T2 (de) 1994-02-24
EP0311467A2 (de) 1989-04-12
JPH0196129A (ja) 1989-04-14
JPH0651621B2 (ja) 1994-07-06
EP0311467B1 (de) 1993-08-04
FR2621486B1 (fr) 1990-01-26
US4904684A (en) 1990-02-27
EP0311467A3 (en) 1990-12-12

Similar Documents

Publication Publication Date Title
DE69625518D1 (de) Wirkstoff zur behandlung neurodegenerativer störungen
ATE94387T1 (de) Verwendung von n-myristoyl-(s)-phenylalanin zur herstellung eines medikaments zur behandlung von krankheiten mittels hemmung der myristoylierung.
DE69526956D1 (de) Proteinkinase c-inhibitoren zur behandlung von neurologischen erkrankungen
DE3885366D1 (de) Verfahren zur Herstellung von Pyrrolo-(3,4-c)pyrrolen.
FI891252A0 (fi) 1,3,4,5-tetrahydrobenz /c,d/ indol.
AU1808488A (en) Compounds for the treatment of alzheimer's disease
AU7535087A (en) The process for the manufacture of spiro-linked pyrrolidine-2,5-dione derivatives
NO174149C (no) Fremgangsmåte for fremstilling av 4-(di-n-propyl)-amino-6-aminokarbonyl-1,3,4,5-tetrahydrobenz-(cd)indolhippurat
DE3769691D1 (de) Substituierte oximether, ihre verwendung als bioregulatoren zur senkung des endogenen ethylenspiegels in pflanzen.
NO884533D0 (no) Fremgangsmaate for fremstilling av derivater av 2,2-dimetylkromen.
ATE92317T1 (de) Verwendung von pyrrol(3,2,1-hi>indol-derivaten zur herstellung eines arzneimittels zur behandlung von diabetes.
NO169125C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 10-substituerte 9-fluor-7-okso-2,3-dihydro-7h-pyrido(3.2.1-ij)-1,3,4-benzoksadiazin-6-karboksylsyrederivater
ATE191476T1 (de) Verfahren zur herstellung von indolderivaten
DE3688397D1 (de) 3-(2-aminoethyl)indol und -indolinderivate, verfahren zu ihrer herstellung und diese derivate enthaltende pharmazeutische zusammensetzungen.
DE69109243D1 (de) Verfahren zur Herstellung von L-Tryptophan und L-Threonine.
DE3764559D1 (de) 4-benzyloxy-3-pyrrolin-2-on-1-yl-acetamid, dessen herstellung und verwendung.
ATE78395T1 (de) Verwendung von dopamin-agonisten zur herstellung eines arzneimittels zur behandlung von psychostimulant-sucht.
ATE70060T1 (de) Neue tetrahydro-benzothiazole, ihre herstellung und verwendung.
DE3887212D1 (de) Verfahren zur Herstellung von Derivaten von 6,7-Diazyl-7-desacetylforskolin.
DE59005519D1 (de) Verfahren zur Herstellung von 5-(Carbamoyl)-5H-dibenz[b,f]azepin.
DE69019843D1 (de) Verfahren zur Herstellung von NADH-Oxydase.
HUT56541A (en) Process for producing 6-substituted hexahydrobenz(c,d)indole derivatives and pharmaceutical preparatives containing these compounds as active substance
ATE195072T1 (de) Verwendung von 6,7-substituierten-2- aminotetraline zur herstellung von pharmazeutischen zusammensetzungen zur behandlung von septischem schock, und antipyretischer und antientzündlicher zusammensetzungen
DE69027577D1 (de) Verwendung von Benzothiazepinen zur Herstellung von Arzneimitteln zur Behandlung von epileptischen Anfällen
DE68917994D1 (de) Verfahren zur Herstellung von Pyrrolizinderivaten.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee